Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Barton

Showing results (11-20 of 143) with videos related to

Pageof 15
Sort By:
Current Opinion in Pharmacology|June 1, 2013
Mechanisms and therapy of atherosclerosis and its clinical complicationsMatthias Barton
Current Opinion in Pharmacology|June 8, 2013
Prevention and endothelial therapy of coronary artery diseaseMatthias Barton
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 11, 2005
Ageing as a determinant of renal and vascular disease: role of endothelial factorsMatthias Barton
Contributions to Nephrology|September 7, 2011
Endothelin antagonism and reversal of proteinuric renal disease in humansMatthias Barton
Steroids|February 28, 2016
Not lost in translation: Emerging clinical importance of the G protein-coupled estrogen receptor GPERMatthias Barton
Arteriosclerosis, Thrombosis, and Vascular Biology|January 24, 2019
Primum Non Nocere: Why Calcitriol («Vitamin» D) Hormone Therapy Is Not a Magic BulletMatthias Barton
Seminars in Nephrology|May 13, 2015
Endothelin and the glomerulus in chronic kidney diseaseMatthias Barton, Andrey Sorokin
The Journal of Physiology|December 2, 2016
Obesity causes lymphatic vascular injury: time for clinical translationMatthias Barton, Marc Husmann
Cardiovascular Research|February 27, 2004
Protease-activated receptors and EDHF: the icing on the cake?Tobias Traupe, Matthias Barton
Hypertension (Dallas, Tex. : 1979)|November 5, 2019
Endothelin: 30 Years From Discovery to TherapyMatthias Barton, Masashi Yanagisawa
Pageof 15

Showing results (11-20 of 143) with videos related to

Sort By:
Pageof 15
Current Opinion in Pharmacology|June 1, 2013
Mechanisms and therapy of atherosclerosis and its clinical complicationsMatthias Barton
Current Opinion in Pharmacology|June 8, 2013
Prevention and endothelial therapy of coronary artery diseaseMatthias Barton
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 11, 2005
Ageing as a determinant of renal and vascular disease: role of endothelial factorsMatthias Barton
Contributions to Nephrology|September 7, 2011
Endothelin antagonism and reversal of proteinuric renal disease in humansMatthias Barton
Steroids|February 28, 2016
Not lost in translation: Emerging clinical importance of the G protein-coupled estrogen receptor GPERMatthias Barton
Arteriosclerosis, Thrombosis, and Vascular Biology|January 24, 2019
Primum Non Nocere: Why Calcitriol («Vitamin» D) Hormone Therapy Is Not a Magic BulletMatthias Barton
Seminars in Nephrology|May 13, 2015
Endothelin and the glomerulus in chronic kidney diseaseMatthias Barton, Andrey Sorokin
The Journal of Physiology|December 2, 2016
Obesity causes lymphatic vascular injury: time for clinical translationMatthias Barton, Marc Husmann
Cardiovascular Research|February 27, 2004
Protease-activated receptors and EDHF: the icing on the cake?Tobias Traupe, Matthias Barton
Hypertension (Dallas, Tex. : 1979)|November 5, 2019
Endothelin: 30 Years From Discovery to TherapyMatthias Barton, Masashi Yanagisawa
Pageof 15